Tozaride: Targeted & Personalized Therapy for Small Cell Lung and Neuroendocrine Cancer

Email address:

First name:

Last name:

Job title:

Company name:

Country:

I work for

Please specify your industry *

please check before submitting

Mobile number:

What is your role?

Privacy statement »

Manage your email preferences »

Remember my details Information

Remember my details

We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

close »

Chris Adams of Andarix Pharmaceuticals joined us for World Orphan Drug Congress USA 2015 to present about ' Tozaride: Targeted & Personalized Therapy for Small Cell Lung and Neuroendocrine Cancer'

Download his presentation to understand more about:

Receptor-targeted therapy
Tozaride Key Properties
Vixilide--Clinical Data

...and much more!

Get your copy here!

To find out more about personalized therapy for small cell lung and neuroendocrine cancer , attend World Orphan Drug Congress USA 2016 April 20-22 in Washington, DC.

Tozaride: Targeted & Personalized Therapy for Small Cell Lung and Neuroendocrine Cancer

information we require

please check before submitting